Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
Public ClinicalTrials.gov record NCT02500706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in Asia, Europe and North America. The purpose is to confirm efficacy in terms of glycaemic control of treatment with mealtime faster-acting insulin aspart in combination with insulin degludec in adults with Type 1 Diabetes Mellitus.
Study identification
- NCT ID
- NCT02500706
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,108 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2016 (Actual)
- Primary completion
- Jul 17, 2017 (Actual)
- Completion
- Aug 16, 2017 (Actual)
- Last update posted
- Jun 12, 2019
2016 – 2017
United States locations
- U.S. sites
- 57
- U.S. states
- 24
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Tucson | Arizona | 85714 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Encino | California | 91436 | — |
| Novo Nordisk Investigational Site | Escondido | California | 92025 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Fullerton | California | 92835 | — |
| Novo Nordisk Investigational Site | Huntington Beach | California | 92648 | — |
| Novo Nordisk Investigational Site | Monterey | California | 93940 | — |
| Novo Nordisk Investigational Site | Newport Beach | California | 92663 | — |
| Novo Nordisk Investigational Site | Santa Barbara | California | 93105 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80209 | — |
| Novo Nordisk Investigational Site | Golden | Colorado | 80401 | — |
| Novo Nordisk Investigational Site | Palm Harbor | Florida | 34684 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33607 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30076 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Baltimore | Maryland | 21204 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Flint | Michigan | 48503-5904 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49048 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416 | — |
| Novo Nordisk Investigational Site | Jefferson City | Missouri | 65109 | — |
| Novo Nordisk Investigational Site | Las Vegas | Nevada | 89148 | — |
| Novo Nordisk Investigational Site | Nashua | New Hampshire | 03063 | — |
| Novo Nordisk Investigational Site | Hamilton | New Jersey | 08690 | — |
| Novo Nordisk Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Investigational Site | Albuquerque | New Mexico | 87109-2134 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12206 | — |
| Novo Nordisk Investigational Site | Rochester | New York | 14607 | — |
| Novo Nordisk Investigational Site | Chapel Hill | North Carolina | 27517 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Wilmington | North Carolina | 28401 | — |
| Novo Nordisk Investigational Site | Bend | Oregon | 97702 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78731 | — |
| Novo Nordisk Investigational Site | Austin | Texas | 78749 | — |
| Novo Nordisk Investigational Site | Beaumont | Texas | 77701 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75218 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | Mesquite | Texas | 75149 | — |
| Novo Nordisk Investigational Site | Round Rock | Texas | 78681 | — |
| Novo Nordisk Investigational Site | Murray | Utah | 84123 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84405 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84102 | — |
| Novo Nordisk Investigational Site | Salt Lake City | Utah | 84107 | — |
| Novo Nordisk Investigational Site | Federal Way | Washington | 98003 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99201 | — |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02500706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2019 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02500706 live on ClinicalTrials.gov.